omega-n-methylarginine has been researched along with Thrombopenia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barbosa, JB; Brunini, TM; Mann, GE; Matsuura, C; Mendes-Ribeiro, AC; Moraes, TL; Moss, MB; Neto, ML; Siqueira, MA | 1 |
Alak, AM; Cromeens, DM; Flaherty, MJ; Griffith, OW; Gross, SS; Kilbourn, RG; Owen-Schaub, LB; Santee, SM | 1 |
2 other study(ies) available for omega-n-methylarginine and Thrombopenia
Article | Year |
---|---|
Nitric oxide activity in platelets of dengue haemorrhagic fever patients: the apparent paradoxical role of ADMA and l-NMMA.
Topics: Adult; Arginine; Blood Platelets; Brazil; Enzyme Inhibitors; Female; Humans; Male; Nitric Oxide Synthase; omega-N-Methylarginine; Platelet Aggregation; Severe Dengue; Thrombocytopenia | 2012 |
NG-methyl-L-arginine, an inhibitor of nitric oxide formation, reverses IL-2-mediated hypotension in dogs.
Topics: Animals; Antineoplastic Agents; Arginine; Blood Pressure; Blood Urea Nitrogen; Cell Division; Creatinine; Dogs; Enzymes; Glioma; Hypotension; Interleukin-2; Killer Cells, Lymphokine-Activated; Leukocyte Count; Lymphocytes; Male; Monocytes; Nitric Oxide; omega-N-Methylarginine; Thrombocytopenia; Tumor Cells, Cultured | 1994 |